Stefan Rose‐John

Active 1988–2024

277
Papers
57,058
Citations
128
h-index
273
i10-index

Citations

Citations per year for Stefan Rose‐John1988: 1 citations1989: 1 citations1990: 5 citations1991: 8 citations1992: 12 citations1993: 32 citations1994: 55 citations1995: 45 citations1996: 67 citations1997: 135 citations1998: 145 citations1999: 175 citations2000: 203 citations2001: 199 citations2002: 229 citations2003: 244 citations2004: 240 citations2005: 300 citations2006: 423 citations2007: 352 citations2008: 339 citations2009: 403 citations2010: 473 citations2011: 630 citations2012: 595 citations2013: 653 citations2014: 677 citations2015: 667 citations2016: 745 citations2017: 892 citations2018: 769 citations2019: 2,033 citations2020: 2,516 citations2021: 2,949 citations2022: 2,005 citations2023: 1,444 citations2024: 2,203 citations2025: 1,109 citations2026: 42 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,366 citing papers, 23.8% of this breakdownChina: 3,210 citing papers, 14.2% of this breakdownGermany: 1,983 citing papers, 8.8% of this breakdownUnited Kingdom: 1,305 citing papers, 5.8% of this breakdownItaly: 912 citing papers, 4% of this breakdownJapan: 778 citing papers, 3.5% of this breakdownAustralia: 716 citing papers, 3.2% of this breakdownFrance: 678 citing papers, 3% of this breakdownCanada: 651 citing papers, 2.9% of this breakdownSpain: 503 citing papers, 2.2% of this breakdownNetherlands: 442 citing papers, 2% of this breakdownSouth Korea: 384 citing papers, 1.7% of this breakdown
0%23.8%Other 24.9%

Fields

  • Medicine53.3%
  • Biochemistry, Genetics and Molecular Biology20.5%
  • Immunology and Microbiology14.7%
  • Neuroscience6.8%
  • Agricultural and Biological Sciences0.9%
  • Nursing0.7%
  • Other3.1%

Topics

  • Cytokine Signaling Pathways and Interactions3.7%
  • Immune Cell Function and Interaction2.5%
  • Immune cells in cancer2.2%
  • Immune Response and Inflammation2%
  • Neuroinflammation and Neurodegeneration Mechanisms1.7%
  • Immunotherapy and Immune Responses1.6%
  • Other86.3%

Coauthors

All papers

Open in search
  1. Targeting IL-6 trans-signalling: past, present and future prospects

    Authors: , , , , - Nature reviews. Immunology 2023 cited by 472

  2. The pro- and anti-inflammatory properties of the cytokine interleukin-6

    Authors: , , , - Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011 cited by 3,190

  3. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2016 cited by 1,084

  4. IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer

    Authors: , , , , , , , , , , - Cancer Cell 2009 cited by 2,117

  5. Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner

    Authors: , , , , , , , , , , , , - Cell 2020 cited by 539

  6. IL-6 pathway in the liver: From physiopathology to therapy

    Authors: , - Journal of Hepatology 2016 cited by 866

  7. Interleukin-6: designing specific therapeutics for a complex cytokine

    Authors: , , , - Nature Reviews Drug Discovery 2018 cited by 646

  8. IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6

    Authors: - International Journal of Biological Sciences 2012 cited by 1,010

  9. Interleukin-6 Family Cytokines

    Authors: - Cold Spring Harbor Perspectives in Biology 2017 cited by 792

  10. A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia

    Authors: , , , , , , , , , , , - Cell Metabolism 2014 cited by 739

  11. STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 327

  12. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Carugo, Gioacchino Natoli, Andrea Viale - Science 2021 cited by 258

  13. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2021 cited by 250

  14. The role of interleukin-6 signaling in nervous tissue

    Authors: , , - Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2016 cited by 503

  15. Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer

    Authors: , , , , , , , , , , , - Cancer Cell 2011 cited by 847

  16. Interleukin-6 and its receptors: A highly regulated and dynamic system

    Authors: , , - Cytokine 2014 cited by 611

  17. The role of IL-6 in host defence against infections: immunobiology and clinical implications

    Authors: , , - Nature Reviews Rheumatology 2017 cited by 424

  18. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2016 cited by 387

  19. Interleukin-6: obstacles to targeting a complex cytokine in critical illness

    Authors: , , , - The Lancet Respiratory Medicine 2021 cited by 267

  20. Interleukin-6: Biology, signaling and strategies of blockade

    Authors: , - Cytokine & Growth Factor Reviews 2015 cited by 504

  21. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition

    Authors: , , - Current Opinion in Immunology 2015 cited by 432

  22. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2000 cited by 1,289

  23. Plasticity and cross-talk of Interleukin 6-type cytokines

    Authors: , , , , , , - Cytokine & Growth Factor Reviews 2012 cited by 397

  24. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

    Authors: , , , , , , , , , , , , - Blood 2003 cited by 721